Ialugen Plus

Sulfadiazine Silver, the active ingredient in Ialugen Plus, is an antimicrobial agent presented as a topical formulation for skin application. It is used to manage infected burn wounds and other skin lesions, helping to control bacterial growth and support tissue repair. GNH USA supplies Ialugen Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ialugen Plus acts on bacterial contamination and impaired skin integrity, making it suitable for several wound‑care indications.

Burn wounds: promotes healing while reducing infection risk. Infected skin lesions: delivers broad‑spectrum antimicrobial activity to control local infection. Chronic wounds (e.g., pressure ulcers): supports tissue repair and maintains extracellular matrix hydration.

Ialugen Plus may cause local and systemic adverse reactions.

Common Side Effects: - Mild skin irritation or redness at the application site. - Itching or burning sensation. - Dryness or peeling of the treated area. - Localized allergic dermatitis.

Serious or Rare Side Effects: - Severe contact dermatitis or hypersensitivity reaction. - Systemic silver accumulation (argyria) with extensive use. - Rare systemic hypersensitivity such as Stevens‑Johnson syndrome.

When using Ialugen Plus, consider the following safety measures. - Sulfonamide allergy: avoid if the patient has known hypersensitivity to sulfonamides. - Silver allergy: discontinue if signs of local or systemic silver reaction appear. - Large surface area application: limit to avoid systemic absorption, especially in patients with renal impairment. - Renal function: monitor in patients with existing kidney disease. - Store at room temperature: keep in the original container, protect from moisture and light.

Topical sulfadiazine silver can interact with systemic medications and other topical agents.

Major Interactions (Avoid): - Systemic sulfonamides or trimethoprim: may increase risk of sulfonamide toxicity. - Warfarin: potential enhancement of anticoagulant effect. - Methotrexate: increased risk of hematologic toxicity.

Moderate Interactions (Monitor Closely): - Topical antibiotics (e.g., bacitracin): may increase local irritation. - Phototherapy or UV exposure: could potentiate skin sensitivity.